跳到正文
The Decoder· Manuel Uth·· 6 天前AI 評分50

Moonshot AI 因編碼基準測試進步趨緩,將 Kimi 模型轉向科學研究

Moonshot AI pivots Kimi models from coding to science as benchmark gains flatten

AI 導讀

Moonshot AI 因編碼領域的基準測試進步趨緩,正把 Kimi 語言模型轉向生物學、化學及製藥研究。北京初創公司 DP Technology 正將 Kimi K3.1 Pro 整合至研究助理 BioMaster;一次測試中,模型分析 3,696 個小鼠胰臟細胞的基因資料,在 90 分鐘內標出 100 個候選基因,估計相當於人類四小時的工作量。

正文

Because Moonshot AI sees diminishing returns in coding, the Beijing startup is redirecting its Kimi language models toward biology, chemistry, and pharma research. International director Giacomo Ficari said at the Web Summit in Lisbon that science demands smarter AI models than law, finance, or code.

Beijing startup DP Technology is integrating Kimi K3.1 Pro into its research assistant BioMaster. In one test, the AI analyzed gene data from 3,696 mouse pancreatic cells and flagged 100 candidate genes in 90 minutes instead of an estimated four hours of human work.

Fully independent breakthroughs are still a long way off. On TCSExam, a 100-problem theoretical CS benchmark, leading models produced verifiable proofs but couldn't crack any open conjectures alone. US rivals hit similar limits. Anthropic's Claude found an enzyme system in September, but mathematicians criticized OpenAI's claimed math and physics breakthroughs. The pharma industry isn't sold yet either. A June Citi survey of 50 US research leaders found 72 percent already using AI broadly, but only 24 percent expect it to noticeably improve drug development success rates.

AI News Without the Hype – Curated by Humans

Subscribe to THE DECODER for ad-free reading, a weekly AI newsletter, our exclusive "AI Radar" frontier report six times a year, full archive access, and access to our comment section.

來源:The Decoder · the-decoder.com